Stack Financial Management Inc raised its stake in Danaher Corporation (NYSE:DHR) by 1.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 256,739 shares of the conglomerate’s stock after buying an additional 3,360 shares during the period. Danaher Corporation comprises 2.4% of Stack Financial Management Inc’s holdings, making the stock its 11th biggest holding. Stack Financial Management Inc’s holdings in Danaher Corporation were worth $22,023,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently added to or reduced their stakes in the company. GQG Partners LLC bought a new stake in shares of Danaher Corporation in the 2nd quarter valued at about $101,000. Proficio Capital Partners LLC raised its holdings in shares of Danaher Corporation by 92.3% in the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after purchasing an additional 598 shares in the last quarter. Monetary Management Group Inc. raised its holdings in shares of Danaher Corporation by 10.7% in the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after purchasing an additional 150 shares in the last quarter. Acrospire Investment Management LLC raised its holdings in shares of Danaher Corporation by 185.5% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after purchasing an additional 1,100 shares in the last quarter. Finally, ClariVest Asset Management LLC bought a new stake in shares of Danaher Corporation in the 1st quarter valued at about $157,000. 75.38% of the stock is owned by institutional investors.
Shares of Danaher Corporation (NYSE DHR) opened at $93.19 on Wednesday. The firm has a market cap of $64,920.83, a P/E ratio of 23.99, a price-to-earnings-growth ratio of 2.22 and a beta of 1.02. Danaher Corporation has a 12-month low of $76.27 and a 12-month high of $93.38. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43.
Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. Danaher Corporation’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.87 EPS. equities analysts expect that Danaher Corporation will post 3.99 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a yield of 0.60%. The ex-dividend date was Thursday, September 28th. Danaher Corporation’s dividend payout ratio is presently 16.52%.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://sportsperspectives.com/2017/11/15/stack-financial-management-inc-grows-holdings-in-danaher-corporation-dhr.html.
In other news, CAO Robert S. Lutz sold 11,189 shares of the company’s stock in a transaction on Monday, October 23rd. The shares were sold at an average price of $91.66, for a total value of $1,025,583.74. Following the sale, the chief accounting officer now directly owns 18,314 shares of the company’s stock, valued at approximately $1,678,661.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the company’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the completion of the sale, the chief executive officer now directly owns 271,737 shares in the company, valued at $25,173,715.68. The disclosure for this sale can be found here. In the last three months, insiders have sold 279,628 shares of company stock worth $25,304,394. 12.20% of the stock is owned by insiders.
Several equities research analysts have recently commented on the stock. Robert W. Baird boosted their price target on shares of Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Credit Suisse Group boosted their price target on shares of Danaher Corporation from $93.00 to $96.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Morgan Stanley boosted their price target on shares of Danaher Corporation from $95.00 to $98.00 and gave the company an “overweight” rating in a report on Friday, October 20th. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a report on Thursday, October 5th. Finally, Cowen and Company restated a “buy” rating and issued a $90.00 price target on shares of Danaher Corporation in a report on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. Danaher Corporation presently has an average rating of “Buy” and a consensus target price of $93.31.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.